Dr. Lim's primary clinical and research interests are focused on acute and chronic liver diseases, with emphasis on: 1) Chronic hepatitis B and C infections; 2) Fatty liver disorders, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH); and 3) Complications of cirrhosis and portal hypertension.
I would be pleased to work with trainees and scientists who are interested in studying health outcomes in patients with chronic liver disease, with particular attention to chronic hepatitis B and C infections, fatty liver disease, liver cirrhosis and complications of portal hypertension, and hepatocellular carcinoma. I am an investigator in several national or international multicenter cohort studies evaluating health outcomes focused on hepatitis B and hepatitis C therapy, and a VA cohort study evaluating liver disease outcomes in patients with or without HIV coinfection.
Delivery of Health Care; Hepatitis D; Fatty Liver; Health Services Research; Hepatitis B; Hepatitis C; Carcinoma, Hepatocellular; Liver Cirrhosis; Liver Neoplasms; Quality of Health Care; Clinical Trial
Hepatitis
| Conditions | Study Title |
|---|---|
| Diseases of the Digestive System - Liver | A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3) |
| Diseases of the Digestive System - Liver | Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) (MIRNA) |
| Diseases of the Digestive System - Liver | A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH (VOYAGE) |
| Hepatitis | An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection |